Latest Articles

  • Clinical outcomes in diabetes: It’s not just the glucose (and it’s not so simple)
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine September 2019, 86 (9) 573-574; DOI: https://doi.org/10.3949/ccjm.86b.09019

    As we dig deeper into the reduction in cardiovascular deaths seen with some newer drugs, several questions arise.

  • Aspirin: 4,000 years and still learning
    Kenneth C. Cummings, MD, MS, FASA
    Cleveland Clinic Journal of Medicine August 2019, 86 (8) 522-524; DOI: https://doi.org/10.3949/ccjm.86a.19041

    What we know about aspirin—and what we still need to learn.

  • Should we stop aspirin before noncardiac surgery?
    Anbazhagan Prabhakaran, MD, MRCP (Edin), FACP and Christopher Whinney, MD, SFHM, FACP
    Cleveland Clinic Journal of Medicine August 2019, 86 (8) 518-521; DOI: https://doi.org/10.3949/ccjm.86a.18075

    It depends on the type of surgery and the reason the patient is taking aspirin.

  • Osteonecrosis of the femoral head with subchondral collapse
    Nicolas S. Piuzzi, MD, Hiba K. Anis, MD and George F. Muschler, MD
    Cleveland Clinic Journal of Medicine August 2019, 86 (8) 511-512; DOI: https://doi.org/10.3949/ccjm.86a.19004

    A 45-year-old woman had been taking corticosteroids long-term after organ transplant.

  • Do patients on biologic drugs for rheumatic disease need PCP prophylaxis?
    Joy-Ann Tabanor, MBBS and Santhanam Lakshminarayanan, MBBS
    Cleveland Clinic Journal of Medicine July 2019, 86 (7) 449-453; DOI: https://doi.org/10.3949/ccjm.86a.18084

    Consider it in those with granulomatosis with polyangiitis or pulmonary disease, or those on high-dose steroids.

  • Clinical trials: More to learn than the results
    Brian F. Mandell, MD
    Cleveland Clinic Journal of Medicine July 2019, 86 (7) 437-438; DOI: https://doi.org/10.3949/ccjm.86b.07019

    The details of the GIACTA trial challenge and reaffirm some of our clinical impressions about giant cell arteritis.

  • Type 2 diabetes: Evolving concepts and treatment
    Eden Miller, DO, Richard B. Aguilar, MD, Mary E. Herman, PhD and Stanley S. Schwartz, MD
    Cleveland Clinic Journal of Medicine July 2019, 86 (7) 494-504; DOI: https://doi.org/10.3949/ccjm.86a.17107

    Preserving beta cells is key. Recent studies provide compelling argument regarding treatments of choice.

  • Disseminated invasive aspergillosis in an immunocompetent patient
    Jessica McLaughlin, DO, Eric Libre, MD, FCCP, Amanda Morgan, MD and Svetolik Djurkovic, MD, FCCP
    Cleveland Clinic Journal of Medicine June 2019, 86 (6) 369-370; DOI: https://doi.org/10.3949/ccjm.86a.18093

    The patient, who has COPD, will require lifelong antifungal treatment.

  • Women’s health 2019: Osteoporosis, breast cancer, contraception, and hormone therapy
    Anna Camille Moreno, DO, NCMP, Sabrina Kaur Sahni, MD, NCMP, Taryn L. Smith, MD and Pelin Batur, MD, FACP, NCMP, CCD
    Cleveland Clinic Journal of Medicine June 2019, 86 (6) 400-406; DOI: https://doi.org/10.3949/ccjm.86a.18130

    Vignettes with practical advice based on current literature.

  • Can procalcitonin guide decisions about antibiotic management?
    Robert J. Fakheri, MD
    Cleveland Clinic Journal of Medicine May 2019, 86 (5) 307-311; DOI: https://doi.org/10.3949/ccjm.86a.18074

    Yes, but clinical judgment must still be exercised.

Pages